Dr. Teresa Guerrero
Welcome to A Better Me by Dr. G, your premiere destination for effective and sustainable weight loss.
Our founder, Dr. Guerrero, understands the challenges of achieving a healthy weight and the impact it can have on your overall well-being. That's why she has is bringing this incredible therapy to Texans through telehealth, helping individuals like you achieve their weight loss goals and live their best lives without ever having to step into a doctors office.
Dr. Guerrero is a board certified internal medicine practitioner who has been practicing medicine for over 30 years. She has experience in pediatric medicine, geriatric medicine, and medical aesthetics (to name a few). She is located in Houston, TX and after experiencing her own weight loss journey, is excited to offer patients a 1:1 custom medical weight loss program at a fraction of the cost compared to name brand drugs.
Our clinic offers a safe and effective weight loss solution through Semaglutide or Tirzepatide therapy, FDA-approved medications that have been clinically proven to help patients lose weight and keep it off. Our program is tailored to your unique needs, ensuring that you receive the individual attention and support you need to succeed.
At A Better Me, we believe that weight loss is not just about shedding pounds, but also about gaining confidence, improving your health, and transforming your life. That's why we provide comprehensive support services, including nutritional counseling, exercise guidance, and ongoing monitoring to ensure that you achieve your desired results.
If you're ready to take control of your weight and your health, A Better Me is here to help. Contact us today to learn more about our medical weight loss program and start your journey towards a better you.
Semaglutide is a medication that is used to treat type 2 diabetes and, more recently, has been approved by the FDA for chronic weight management in adults who are overweight or have obesity. It works by mimicking the effects of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which helps to regulate blood sugar levels and reduce appetite. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which mimic the effects of the natural hormone GLP-1 in the body. When used in conjunction with a healthy diet and exercise, semaglutide has been shown to promote weight loss and improve metabolic health.
In terms of weight management, semaglutide has been shown to reduce hunger and increase feelings of fullness, which can lead to decreased food intake and weight loss. The medication is typically used in conjunction with a healthy diet and exercise program to achieve the best results.
Semaglutide is available in a once-weekly injectable form and is typically prescribed by a healthcare provider. As with any medication, it is important to discuss potential benefits and risks with your doctor to determine if it is the right treatment option for you.
Semaglutide injection may increase the risk that you will develop tumors of the thyroid gland, including medullary thyroid carcinoma (MTC; a type of thyroid cancer). Laboratory animals who were given semaglutide developed tumors, but it is not known if this medication increases the risk of tumors in humans. Tell your doctor if you or anyone in your family has or has ever had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2; condition that causes tumors in more than one gland in the body). If so, your doctor will probably tell you not to use semaglutide injection. If you experience any of the following symptoms, call your doctor immediately: a lump or swelling in the neck; hoarseness; difficulty swallowing; or shortness of breath.
Keep all appointments with your doctor and the laboratory. Your doctor may order certain tests to check your body's response to semaglutide injection.
Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with semaglutide injection and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.
Talk to your doctor about the risks of using semaglutide injection.
Tirzepatide is used to treat type 2 diabetes and is approved by the FDA for chronic weight management in adults who are overweight or have obesity. It is a once-weekly injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA).
GLP-1 RAs are a class of medications that mimic the action of the hormone GLP-1, which is naturally produced in the body. GLP-1 helps regulate blood sugar levels by stimulating insulin release, reducing glucagon secretion (a hormone that raises blood sugar levels), slowing down stomach emptying, and promoting a feeling of fullness.
Tirzepatide is unique because it is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. GIP is another hormone involved in regulating blood sugar levels and promoting insulin release.
Clinical trials have shown that tirzepatide has demonstrated superior efficacy in lowering blood sugar levels and achieving weight loss when compared to other GLP-1 RAs. Additionally, tirzepatide has shown potential benefits in reducing cardiovascular risk factors and improving other markers of metabolic health.
Tirzepatide may cause thyroid C-cell tumors. Tell your doctor if you have a personal or family history of thyroid cancer or a condition called Multiple Endocrine Neoplasia (MEN) syndrome (a syndrome that causes tumors to develop on endocrine glands). If you experience any of the following symptoms, call your doctor immediately: lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.
Keep all appointments with your doctor and the laboratory. Your doctor may order certain tests to check your body's response to tirzepatide.
Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with tirzepatide and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) to obtain the Medication Guide.
Talk to your doctor about the risk of taking tirzepatide.